Equities
  • Price (EUR)23.80
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-4.03%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mevis Medical Solutions AG is a Germany-based provider of software and services for the medical image processing industry, and offers computer support for image-based medical diagnosis and therapy. The Company develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The Company's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.

  • Revenue in EUR (TTM)17.64m
  • Net income in EUR5.75m
  • Incorporated2006
  • Employees111.00
  • Location
    Mevis Medical Solutions AGCaroline-Herschel-Str. 1BREMEN 28359GermanyDEU
  • Phone+49 421224950
  • Fax+49 42 122495999
  • Websitehttps://www.mevis.de/
More ▼

Institutional shareholders

20.34%Per cent of shares held by top holders
HolderShares% Held
HANSAINVEST Hanseatische Investment-GmbHas of 31 Mar 2024228.77k12.57%
Aramea Asset Management AGas of 30 Sep 202456.44k3.10%
TBF Global Asset Management GmbHas of 31 Dec 202340.00k2.20%
Axxion SA (Luxembourg)as of 31 Mar 202423.97k1.32%
Knoesel & Ronge Verm�gensverwaltung GmbH & Co. KGas of 29 Feb 202415.31k0.84%
VM Verm�gens-Management GmbHas of 29 Feb 20245.00k0.28%
Greiff Capital Management AGas of 30 Jun 2022700.000.04%
BG Fund Management Luxembourg SAas of 30 Jun 20230.000.00%
More ▼
Data from 29 Feb 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.